Skip to content
Company
About SELLAS
Management Team
Board of Directors
Scientific Advisory Board
Partnerships
Contact Us
Pipeline
Indications
Science
Galinpepimut-S: WT1 Targeting Immunotherapeutic
GPS Proposed Mechanism of Action Animation
SLS009: Highly Selective CDK9 Inhibitor
Publications
Clinical Trials
Ongoing
Completed
Expanded Access Policy
Investors
Overview
News
Events & Presentations
Stock Information
Analyst Coverage
SEC Filings
Corporate Governance
Investors Resources
Careers
Menu
Company
About SELLAS
Management Team
Board of Directors
Scientific Advisory Board
Partnerships
Contact Us
Pipeline
Indications
Science
Galinpepimut-S: WT1 Targeting Immunotherapeutic
GPS Proposed Mechanism of Action Animation
SLS009: Highly Selective CDK9 Inhibitor
Publications
Clinical Trials
Ongoing
Completed
Expanded Access Policy
Investors
Overview
News
Events & Presentations
Stock Information
Analyst Coverage
SEC Filings
Corporate Governance
Investors Resources
Careers
Contact
Careers
Careers
